EMEA-000411-PIP01-08

Key facts

Active substance
  • mifepristone
  • misoprostol
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/156/2009
PIP number
EMEA-000411-PIP01-08
Pharmaceutical form(s)
Tablets
Condition(s) / indication(s)
Medical Abortion
Route(s) of administration
  • Oral use
  • Vaginal use
Contact for public enquiries
Sun Pharmaceutical Industries Europe B.V.

E-mail: secretary.netherlands@sunpharma-europe.com
Country: Netherlands
Phone: +31 235685501
Fax: +31 235685505

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Topics

How useful was this page?

Add your rating